Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
Use this after AAAI reviews are released. AAAI rebuttal space is scarce: the AAAI-26 FAQ allowed a single 2500-character response, disallowed URLs, and discouraged new results. AAAI-27 has not yet published its own rebuttal FAQ — its author feedback window is 2026-10-19 to 10-25 — so treat those limits as the prior cycle's shape and reopen the current FAQ before drafting.
Author feedback at AAAI is read by human reviewers and weighed in SPC/AC discussion, not by the non-decisional AI review. With one short response and no second round, spend every character on the concern most likely to flip a borderline decision. Triage each reviewer point into a lane:
A multi-agent-coordination paper gets two borderline scores. Reviewer 1 wrongly says the protocol ignores communication cost; Reviewer 2 asks for a human-baseline study. Triage: R1 is decision- critical, so sentence one corrects it and cites Section 4's cost ledger; R2's request is out of scope, so one sentence notes the simulator already bounds it and limits the claim to simulated agents. Tone and the AI review's nit are cut to stay under budget.
[Response budget] <characters used / limit>
[Priority issue] <reviewer or AI-review concern>
[Draft rebuttal] <AAAI-ready text, no URLs>
[Submitted evidence anchor] <section/table/figure/checklist/supplement item>
[Cut list] <what to delete if over limit>
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。
Use when explaining or planning around AAAI's two-phase review process, Phase 1 rejection risk, Phase 2 additional reviews, AI-assisted review pilot, author feedback, SPC/AC discussion, and final decisions.
日本語の概要は準備中です。原文の説明を表示しています。